Racial and Ethnic Differences in Mortality and Cardiovascular Events among Patients with End-Stage Renal Disease Due to Lupus Nephritis

Arthritis Care and Research

Volumn 67, Issue 10, 2015, Pages 1453-1462

  Gõmez Puerta, Jose A ^a,d   Feldman, Candace H ^a   Alarcõn, Graciela S ^b   Guan, Hongshu ^a   Winkelmayer, Wolfgang C ^c   Costenbader, Karen H ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE; AMERICAN INDIAN; ARTICLE; ASIAN; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUCASIAN; DEMOGRAPHY; DISEASE REGISTRY; END STAGE RENAL DISEASE; ETHNIC DIFFERENCE; FEMALE; HEART FAILURE; HEART INFARCTION; HEMODIALYSIS; HISPANIC; HOSPITAL ADMISSION; HUMAN; INCIDENCE; KIDNEY TRANSPLANTATION; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; PERITONEAL DIALYSIS; PROBABILITY; PROPORTIONAL HAZARDS MODEL; RACE DIFFERENCE; SEX RATIO; SURVIVAL RATE; SYSTEMIC LUPUS ERYTHEMATOSUS; ANCESTRY GROUP; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COHORT ANALYSIS; COMPARATIVE STUDY; COMPLICATION; CONFIDENCE INTERVAL; ETHNIC GROUP; ETHNOLOGY; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; PROGNOSIS; REGISTER; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEX DIFFERENCE; STATISTICS AND NUMERICAL DATA; SURVIVAL; UNITED STATES; YOUNG ADULT;

ADULT; AGE FACTORS; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COHORT STUDIES; CONFIDENCE INTERVALS; CONTINENTAL POPULATION GROUPS; ETHNIC GROUPS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; LUPUS NEPHRITIS; MALE; MIDDLE AGED; PROGNOSIS; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX FACTORS; SURVIVAL ANALYSIS; UNITED STATES; YOUNG ADULT;

EID: 84942080113     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.22562     Document Type: Article

References (37)

1. Huong DL, Papo T, Beaufils H, Wechsler B, Bletry O, Baumelou A, et al., Renal involvement in systemic lupus erythematosus: a study of 180 patients from a single center. Medicine (Baltimore) 1999; 78: 148-66.
2. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, et al., Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 2003; 82: 299-308.
3. Adler M, Chambers S, Edwards C, Neild G, Isenberg D., An assessment of renal failure in an SLE cohort with special reference to ethnicity, over a 25-year period. Rheumatology (Oxford) 2006; 45: 1144-7.
4. Siso A, Ramos-Casals M, Bove A, Brito-Zeron P, Soria N, Nardi N, et al., Outcomes in biopsy-proven lupus nephritis: evaluation of 190 white patients from a single center. Medicine (Baltimore) 2010; 89: 300-7.
5. Costenbader KH, Desai A, Alarcon GS, Hiraki LT, Shaykevich T, Brookhart MA, et al., Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006. Arthritis Rheum 2011; 63: 1681-8.
6. Sule S, Fivush B, Neu A, Furth S., Increased risk of death in pediatric and adult patients with ESRD secondary to lupus. Pediatr Nephrol 2011; 26: 93-8.
7. Ward MM., Changes in the incidence of end-stage renal disease due to lupus nephritis in the United States, 1996-2004. J Rheumatol 2009; 36: 63-7.
8. Ward MM., Changes in the incidence of end-stage renal disease due to lupus nephritis, 1982-1995. Arch Intern Med 2000; 160: 3136-40.
9. Demas KL, Costenbader KH., Disparities in lupus care and outcomes. Curr Opin Rheumatol 2009; 21: 102-9.
10. Feldman CH, Hiraki LT, Liu J, Fischer MA, Solomon DH, Alarcon GS, et al., Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004. Arthritis Rheum 2013; 65: 753-63.
11. Kucirka LM, Grams ME, Lessler J, Hall EC, James N, Massie AB, et al., Association of race and age with survival among patients undergoing dialysis. JAMA 2011; 306: 620-6.
12. Agodoa L, Eggers P., Racial and ethnic disparities in end-stage kidney failure-survival paradoxes in African-Americans. Semin Dial 2007; 20: 577-85.
13. Arce CM, Goldstein BA, Mitani AA, Winkelmayer WC., Trends in relative mortality between Hispanic and non-Hispanic whites initiating dialysis: a retrospective study of the US renal data system. Am J Kidney Dis 2013; 62: 312-21.
14. Collins AJ, Foley RN, Gilbertson DT, Chen SC., The state of chronic kidney disease, ESRD, and morbidity and mortality in the first year of dialysis. Clin J Am Soc Nephrol 2009; 4 Suppl 1: S5-11.
15. Foley RN, Murray AM, Li S, Herzog CA, McBean AM, Eggers PW, et al., Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol 2005; 16: 489-95.
16. Hak AE, Karlson EW, Feskanich D, Stampfer MJ, Costenbader KH., Systemic lupus erythematosus and the risk of cardiovascular disease: results from the Nurses' Health Study. Arthritis Rheum 2009; 61: 1396-402.
17. Scalzi LV, Hollenbeak CS, Wang L., Racial disparities in age at time of cardiovascular events and cardiovascular-related death in patients with systemic lupus erythematosus. Arthritis Rheum 2010; 62: 2767-75.
18. Hiraki LT, Lu B, Alexander SR, Shaykevich T, Alarcon GS, Solomon DH, et al., End-stage renal disease due to lupus nephritis among children in the US, 1995-2006. Arthritis Rheum 2011; 63: 1988-97.
19. Yap DY, Tang CS, Ma MK, Lam MF, Chan TM., Survival analysis and causes of mortality in patients with lupus nephritis. Nephrol Dial Transplant 2012; 27: 3248-54.
20. Layton JB, Hogan SL, Jennette CE, Kenderes B, Krisher J, Jennette JC, et al., Discrepancy between Medical Evidence Form 2728 and renal biopsy for glomerular diseases. Clin J Am Soc Nephrol 2010; 5: 2046-52.
21. Montez-Rath ME, Winkelmayer WC, Desai M., Addressing missing data in clinical studies of kidney diseases. Clin J Am Soc Nephrol 2014; 9: 1328-35.
22. Ward MM., Socioeconomic status and the incidence of ESRD. Am J Kidney Dis 2008; 51: 563-72.
23. Miller RG., Simultaneous statistical inference. New York (NY): Springer-Verlag; 1981. p. 8.
24. United States Renal Data System. Researcher's guide to the USRDS database. Bethesda (MD); 2008. URL: http://www.usrds.org/research.aspx.
25. Gray R., A class of k-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988; 16: 1141-54.
26. Fine J, Gray RJ., A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496-509.
27. Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, et al., Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010; 375: 2073-81.
28. Young BA, Maynard C, Boyko EJ., Racial differences in diabetic nephropathy, cardiovascular disease, and mortality in a national population of veterans. Diabetes Care 2003; 26: 2392-9.
29. Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, et al., Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 2004; 15: 1307-15.
30. Wetmore JB, Ellerbeck EF, Mahnken JD, Phadnis M, Rigler SK, Mukhopadhyay P, et al., Atrial fibrillation and risk of stroke in dialysis patients. Ann Epidemiol 2013; 23: 112-8.
31. Alarcon GS, McGwin G Jr., Petri M, Reveille JD, Ramsey-Goldman R, Kimberly RP., Baseline characteristics of a multiethnic lupus cohort: PROFILE. Lupus 2002; 11: 95-101.
32. Bastian HM, Roseman JM, McGwin G Jr., Alarcon GS, Friedman AW, Fessler BJ, et al., Systemic lupus erythematosus in three ethnic groups: XII. Risk factors for lupus nephritis after diagnosis. Lupus 2002; 11: 152-60.
33. Pistiner M, Wallace DJ, Nessim S, Metzger AL, Klinenberg JR., Lupus erythematosus in the 1980s: a survey of 570 patients. Semin Arthritis Rheum 1991; 21: 55-64.
34. Borrell LN, Lancet EA., Race/ethnicity and all-cause mortality in US adults: revisiting the Hispanic paradox. Am J Public Health 2012; 102: 836-43.
35. Crimmins EM, Kim JK, Alley DE, Karlamangla A, Seeman T., Hispanic paradox in biological risk profiles. Am J Public Health 2007; 97: 1305-10.
36. Frankenfield DL, Krishnan SM, Ashby VB, Shearon TH, Rocco MV, Saran R., Differences in mortality among Mexican-American, Puerto Rican, and Cuban-American dialysis patients in the United States. Am J Kidney Dis 2009; 53: 647-57.
37. Devlin A, Waikar S, Solomon DH, Lu B, Shaykevich T, Alarcon GS, et al., Variation in initial kidney replacement therapy for end-stage renal disease due to lupus nephritis in the United States. Arthritis Care Res (Hoboken) 2011; 63: 1642-53.